A method of identifying a compound which possesses (i) at least one aspirin activity selected from the group consisting of analgesia, anti-inflammation, fever reduction, COX-1 inhibition, COX-2 inhibition, anti-platelet aggregation and pancreatic cancer prophylaxis, and (ii) no TAFIa-inhibition, comprising the steps of:
- a) exposing TAFIa to the test compound;
- b) determining whether the test compound inhibits TAFIa activity and/or inhibits TAFI activation;
- and
- c) determining whether at least one aspirin activity is retained by the test compound, thereby identifying a compound that possesses at least one aspirin activity but not TAFIa-inhibitory activity.